The aim of this mini-review is to provide a focused analysis of the role of Hsp90 in the pathophysiology of atopic dermatitis and to evaluate the therapeutic potential of its inhibitors as a novel class of disease-modifying agents. Here, HSP90AA1 is linked to atopic eczema.